PCAS
ISIN: FR0000053514 | Ticker: PCA | LEI: 9695009WMW72CD0E3W90
Country: France
With close to 7% of its net sales earmarked for R&D and a large international footprint, PCAS is the preferred industrial partner for market-leading major global groups. The company offers a growing range of proprietary products and solutions in leading-edge segments and also includes very high-potential subsidiary: Protéus in biotechnology. Boasting especially high standards, PCAS generated net sales of €2194,1 million in 2020 and employs more than 1071 people in six countries.
Year founded1962
Served areaWorldwide
Headcount1,071
Headquarters21 Chemin de la Sauvegarde, 69134 Ecully Cedex – France
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 286,326,000.00 | 301,248,000.00 | 319,060,000.00 |
| Noncurrent Assets | N/A | 158,303,000.00 | 162,799,000.00 | 161,165,000.00 |
| Property Plant And Equipment | N/A | 131,525,000.00 | 143,744,000.00 | 154,990,000.00 |
| Deferred Tax Assets | N/A | 7,431,000.00 | 0.00 | 0.00 |
| Noncurrent Derivative Financial Assets | N/A | 910,000.00 | 0.00 | 0.00 |
| Current Assets | N/A | 128,023,000.00 | 138,449,000.00 | 157,895,000.00 |
| Inventories | N/A | 65,008,000.00 | 77,289,000.00 | 72,593,000.00 |
| Current Trade Receivables | N/A | 21,233,000.00 | 19,287,000.00 | 49,209,000.00 |
| Trade And Other Current Receivables Due From Related Parties | N/A | 9,981,000.00 | 2,456,000.00 | 2,194,000.00 |
| Other Current Receivables | N/A | 30,972,000.00 | 30,566,000.00 | 31,044,000.00 |
| Cash and cash equivalents | N/A | 829,000.00 | 8,851,000.00 | 2,855,000.00 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | N/A | 0.00 | 0.00 | 0.00 |
| Equity And Liabilities | N/A | 286,326,000.00 | 301,248,000.00 | 319,060,000.00 |
| Equity | 82,731,000.00 | 67,427,000.00 | 27,823,000.00 | -17,729,000.00 |
| Issued Capital | N/A | 13,742,000.00 | 13,742,000.00 | 13,742,000.00 |
| Retained Earnings Profit Loss For Reporting Period | N/A | N/A | -40,478,000.00 | -48,822,000.00 |
| Share Premium | N/A | 12,047,000.00 | 12,047,000.00 | 12,047,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 67,427,000.00 | 27,823,000.00 | -17,729,000.00 |
| Noncontrolling Interests | N/A | 0.00 | 0.00 | 0.00 |
| Noncurrent Liabilities | N/A | 74,876,000.00 | 78,675,000.00 | 79,262,000.00 |
| Noncurrent Provisions | N/A | 12,257,000.00 | 11,485,000.00 | 7,932,000.00 |
| Deferred Tax Liabilities | N/A | 1,946,000.00 | 2,289,000.00 | 2,792,000.00 |
| Noncurrent Derivative Financial Liabilities | N/A | 0.00 | 369,000.00 | 444,000.00 |
| Longterm Borrowings | N/A | 60,673,000.00 | 64,532,000.00 | 68,094,000.00 |
| Current Liabilities | N/A | 144,023,000.00 | 194,750,000.00 | 257,527,000.00 |
| Current Provisions | N/A | 1,401,000.00 | 1,505,000.00 | 1,396,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 33,622,000.00 | 46,567,000.00 | 49,751,000.00 |
| Trade And Other Current Payables To Related Parties | N/A | 76,655,000.00 | 112,954,000.00 | 159,433,000.00 |
| Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | N/A | 25,450,000.00 | 27,224,000.00 | 41,070,000.00 |
| Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 194,115,000.00 | 187,010,000.00 | 226,356,000.00 |
| Interest Income On Cash And Cash Equivalents | 0.00 | 0.00 | 0.00 |
| Raw Materials And Consumables Used | N/A | 60,428,000.00 | 84,708,000.00 |
| Services Expense | 57,997,000.00 | 61,790,000.00 | 67,604,000.00 |
| Employee Benefits Expense | 73,745,000.00 | 75,247,000.00 | 81,335,000.00 |
| Depreciation And Amortisation Expense | 17,206,000.00 | 19,232,000.00 | 21,218,000.00 |
| Tax Expense Other Than Income Tax Expense | 4,302,000.00 | 3,861,000.00 | 3,882,000.00 |
| Profit Loss From Operating Activities | -10,970,000.00 | -28,590,000.00 | -42,775,000.00 |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | 0.00 | 0.00 | 0.00 |
| Income Tax Expense Continuing Operations | 2,412,000.00 | 8,959,000.00 | 2,913,000.00 |
| Profit Loss From Continuing Operations | -14,947,000.00 | -40,478,000.00 | -48,822,000.00 |
| Profit Loss From Discontinued Operations | 0.00 | 0.00 | 0.00 |
| Profit (loss) | -14,947,000.00 | -40,478,000.00 | -48,822,000.00 |
| Profit Loss Attributable To Owners Of Parent | -14,947,000.00 | -40,478,000.00 | -48,822,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 0.00 | 0.00 | 0.00 |
| Line item in (eur) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Profit (loss) | -14,947,000.00 | -40,478,000.00 | -48,822,000.00 |
| Adjustments For Income Tax Expense | 2,412,000.00 | 8,959,000.00 | 2,913,000.00 |
| Adjustments For Decrease Increase In Inventories | -11,686,000.00 | -12,063,000.00 | 4,639,000.00 |
| Adjustments For Increase Decrease In Trade Account Payable | 824,000.00 | 12,841,000.00 | 3,168,000.00 |
| Other Adjustments For Noncash Items | -1,299,000.00 | 1,286,000.00 | 88,000.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | 61,000.00 | 41,000.00 | 0.00 |
| Cash Flows From Used In Operating Activities | -2,739,000.00 | -4,670,000.00 | -18,387,000.00 |
| Cash Flows From Used In Investing Activities | -30,800,000.00 | -31,522,000.00 | -34,135,000.00 |
| Proceeds From Issuing Shares | 0.00 | 0.00 | 0.00 |
| Proceeds From Borrowings Classified As Financing Activities | 8,240,000.00 | 12,064,000.00 | 10,396,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | 6,898,000.00 | 9,122,000.00 | 8,131,000.00 |
| Interest Paid Classified As Financing Activities | 2,185,000.00 | 2,359,000.00 | 3,266,000.00 |
| Cash Flows From Used In Financing Activities | 34,090,000.00 | 44,407,000.00 | 45,740,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | 20,000.00 | -193,000.00 | -80,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 571,000.00 | 8,022,000.00 | -6,862,000.00 |
| Cash and cash equivalents | 829,000.00 | 8,851,000.00 | 2,855,000.00 |
Please note that some sums might not add up.
FR0000053514
LEI9695009WMW72CD0E3W90
SectorKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.